Assessing cost-effectiveness analyses in rheumatoid arthritis and osteoarthritis. Review uri icon

Overview

abstract

  • Economic considerations are now a source of great concern to clinicians and policy analysts. Many cost-effectiveness analyses have been published in the area of arthritis, most with substantial methodologic deficiencies. The goal of this article is to outline a method for evaluating cost-effectiveness assessment within the field of rheumatology. We do so by critically evaluating 6 cost-effectiveness analyses--2 in rheumatoid arthritis and 4 in osteoarthritis--as a basis for appraising the literature and developing future studies.

publication date

  • December 1, 1997

Research

keywords

  • Arthritis, Rheumatoid
  • Osteoarthritis
  • Outcome Assessment, Health Care

Identity

Scopus Document Identifier

  • 84988220928

Digital Object Identifier (DOI)

  • 10.1002/art.1790100609

PubMed ID

  • 9481233

Additional Document Info

volume

  • 10

issue

  • 6